{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:57:02Z","timestamp":1792173422412,"version":"4.4.0"},"reference-count":15,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"publisher","award":["62847101"],"award-info":[{"award-number":["62847101"]}],"id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Antiphospholipid antibody syndrome (APS) is a rare disease with significant morbidity and the possibility of mortality. While there are no established diagnostic criteria for use in clinical settings, there is a large body of global research organized by the American College of Rheumatology and European Alliance of Associations for Rheumatology (ACR\/EULAR) into accepted research guidelines, developed for identifying probable APS cases. The research guidelines were used in this study as a surrogate approach for evaluating diagnostic testing patterns, with the aim of identifying potential gaps in patient evaluation for APS in clinical settings. For this study, suggested testing for APS characterization included IgG (Immunoglobulin G) and IgM (Immunoglobulin M) anti-cardiolipin antibodies; IgG and IgM anti-beta-2 glycoprotein I antibodies; and Lupus Anticoagulant. This retrospective cross-sectional study identified patients from the electronic medical records of a regional health system with International Classification of Diseases (ICD) diagnostic codes for APS-associated conditions, signs, symptoms, and\/or testing collected for antiphospholipid antibodies in selected medical and surgical specialty locations, from 01\/01\/2011 to 12\/31\/2020. These data were used to assess how closely the clinical testing patterns followed the 2023 ACR\/EULAR criteria for laboratory evaluation. The data showed that 80.70% of 16679 patients with antiphospholipid antibody tests collected did not include all antiphospholipid antibody testing described in 2023 ACR\/EULAR research criteria guidelines. These findings may represent common suboptimal ordering practices in evaluations for APS, highlighting the need for peer comparison and the development of future clinical laboratory guidance to support more complete assessment for APS.<\/jats:p>","DOI":"10.1371\/journal.pone.0359712","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:38:42Z","timestamp":1792172322000},"page":"e0359712","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying diagnostic testing gaps for antiphospholipid syndrome within a single healthcare system"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-9696","authenticated-orcid":true,"given":"Deborah J.","family":"Novak","sequence":"first","affiliation":[{"name":"Geisinger Medical Laboratories, Geisinger","place":["Danville, Pennsylvania, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Grant","sequence":"additional","affiliation":[{"name":"Geisinger Medical Laboratories, Geisinger","place":["Danville, Pennsylvania, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Tice","sequence":"additional","affiliation":[{"name":"Geisinger Medical Laboratories, Geisinger","place":["Danville, Pennsylvania, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Joy","sequence":"additional","affiliation":[{"name":"Thermofisher Scientific","place":["Philadelphia, Pennsylvania, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Dhanya","family":"Mackeen","sequence":"additional","affiliation":[{"name":"Geisinger Commonwealth School of Medicine","place":["Scranton, Pennsylvania, United States of America"]},{"name":"Obstetrics and Gynecology, Maternal and Fetal Medicine, Geisinger","place":["Danville, Pennsylvania, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Wolk","sequence":"additional","affiliation":[{"name":"Geisinger Medical Laboratories, Geisinger","place":["Danville, Pennsylvania, United States of America"]},{"name":"Geisinger Commonwealth School of Medicine","place":["Scranton, Pennsylvania, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"12","key":"pone.0359712.ref001","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"JY Dabit","year":"2022","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"pone.0359712.ref002","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: A population-based study","volume":"71","author":"A Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"pone.0359712.ref003","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"M Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"pone.0359712.ref004","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fimmu.2019.00941","article-title":"Cardiac manifestations of antiphospholipid syndrome with focus on its primary form","volume":"10","author":"T Kolitz","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0359712.ref005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/hematology.2024000673","article-title":"New definitions for antiphospholipid syndrome: ready for clinical use?","volume":"2024","author":"AB Song","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"pone.0359712.ref006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajog.2017.01.026","article-title":"Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: The PREGNANTS study","volume":"216","author":"G Saccone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"pone.0359712.ref007","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"7","key":"pone.0359712.ref008","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria","volume":"67","author":"R Aggarwal","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"17","key":"pone.0359712.ref009","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"V Pengo","year":"2011","journal-title":"Blood"},{"issue":"2","key":"pone.0359712.ref010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0961203316657433","article-title":"Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity","volume":"26","author":"CM Yelnik","year":"2017","journal-title":"Lupus"},{"issue":"11","key":"pone.0359712.ref011","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"KMJ Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"2","key":"pone.0359712.ref012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jtha.2024.10.022","article-title":"An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: Guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"23","author":"KMJ Devreese","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"11","key":"pone.0359712.ref013","article-title":"The landscape of inappropriate laboratory testing: A 15-year meta-analysis","volume":"8","author":"M Zhi","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"pone.0359712.ref014","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5009\/gnl230272","article-title":"Challenges in and opportunities for electronic health record-based data analysis and interpretation","volume":"18","author":"MK Kim","year":"2024","journal-title":"Gut Liver"},{"issue":"9","key":"pone.0359712.ref015","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/gim.2015.187","article-title":"The Geisinger MyCode community health initiative: An electronic health record-linked biobank for precision medicine research","volume":"18","author":"DJ Carey","year":"2016","journal-title":"Genet Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:38:45Z","timestamp":1792172325000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359712"}},"subtitle":[],"editor":[{"given":"Marwan Salih","family":"Al-Nimer","sequence":"first","affiliation":[{"name":"University of Diyala College of Medicine","place":["IRAQ"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0359712","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}